CC BY-NC-ND 4.0 · European Journal of General Dentistry 2014; 3(01): 46-52
DOI: 10.4103/2278-9626.126211
Original Article

Cytogenetic biomonitoring of premalignant and malignant oral lesions by micronuclei assessment: A screening evaluation

Shally Khanna
Department of Oral Pathology and Microbiology, Purvanchal Institute of Dental Sciences, Gorakhpur, Uttar Pradesh, India
Anupam Purwar
1   Department of Prosthodontics, Purvanchal Institute of Dental Sciences, Gorakhpur, Uttar Pradesh, India
Narendra Nath Singh
2   Department of Oral Pathology and Microbiology, Kothiwal Dental College and Research Centre, Moradabad, Uttar Pradesh, India
Gadiputi Sreedhar
2   Department of Oral Pathology and Microbiology, Kothiwal Dental College and Research Centre, Moradabad, Uttar Pradesh, India
Shailendra Singh
3   Department of Orthodontics, Azamgarh Dental College, Azamgarh, Uttar Pradesh, India
Saurabh Bhalla
4   Department of Orthodontics, Purvanchal Institute of Dental Sciences, Gorakhpur, Uttar Pradesh, India
› Author Affiliations


Background: Micronuclei (MN) are extracytoplasmic nuclear bodies, which are induced in cells by numerous genotoxic agents that damage the chromosomes. The damaged chromosomes in the form of acentric chromatids or chromosome fragments lag behind in anaphase when centric elements move towards the spindle poles, and thus leads to the formation of secondary nuclei called MN, which are also transmitted to the daughter cells. In oral exfoliated cells these MN are induced by variety of carcinogenic compounds like tobacco, betel nut, and alcohol; which have been suggested to be the most common cause of premalignant lesion conditions and oral cancer, and thus can be used as a biomarker for cytogenetic damage. Objectives: To evaluate and compare the frequency of MN in Papanicolaou (PAP) stained smears of oral exfoliated cells from healthy control, leukoplakia, and squamous cell carcinoma (SCC) group in a small population of eastern Uttar Pradesh. Materials and Methods: Cytological smears were prepared from buccal mucosa of healthy control, leukoplakia patients, and SCC group and stained with PAP stain. Slides were screened, and micronucleated cells were counted out of thousand and compared in different groups. Results: Mean MN count was highest for the SCC group (10.13), followed by leukoplakia group (6.15), and lowest for healthy controls (3.28); with count ranging from 7-14, 4-8, and 2-4, respectively. Tukey′s HSD and ROC analysis showed the intergroup differences were significant statistically (P < 0.05) and thus, mean MN density seems to be a useful tool for differential diagnosis with high accuracy. Conclusion: MN were higher in SCC than in leukoplakia and healthy control, moreover. Hence, MN assay can be used as an important biomarker for cytogenetic damage in oral leukoplakia and SCC.

Publication History

Article published online:
01 November 2021

© 2014. European Journal of General Dentistry. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • References

  • 1 Petersen PE. Oral healthcare in people living with cancer. Oral Oncol 2010;46:399-400.
  • 2 Warnakulasuriya S. Living with oral cancer: Epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol 2010;46:407-10.
  • 3 Attar E, Dey S, Hablas A, Seifeldin IA, Ramadan M, Rozek LS, et al. Head and neck cancer in a developing country: A population-based perspective across 8 years. Oral Oncol 2010;46:591-6.
  • 4 Amarasinghe HK, Usgodaarachchi US, Johnson NW, Lalloo R, Warnakulasuriya S. Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: A case-control study. Oral Oncol 2010;46:297-301.
  • 5 Sellappa S, Balakrishnan M, Raman S, Palanisamy S. Induction of micronuclei in buccal mucosa on chewing a mixture of betel leaf, areca nut and tobacco. J Oral Sci 2009;51:289-92.
  • 6 Khanna S. Immunological and biochemical markers in oral carcinogenesis: The public health perspective. Int J Environ Res Public Health 2008;5:418-22.
  • 7 Slaughter DP, Southwick HW, Smejkal W. ′Field cancerization′ in oral stratified squamous epithelium. Cancer 1953;6:963-68.
  • 8 Proia NK, Paszkiewicz GM, Nasca MA, Franke GE, Pauly JL. Smoking and smokeless tobacco-associated human buccal cell mutations and their association with oral cancer-a review. Cancer Epidemiol Biomarkers Prev 2006;15:1061-77.
  • 9 Palve DH, Tupkari JV. Clinicopathological correlation of micronuclei in oral squamous cell carcinoma by exfoliative cytology. J Oral Maxillofac Pathol 2008;12:2-7.
  • 10 Halder A, Chakraborty T, Mandal K, Gure PK, Das S, Raychowdhury R, et al. Comparative study of exfoliated oral mucosal cell micronuclei frequency in normal, precancerous and malignant epithelium. Int J Hum Genet 2004;4:257-60.
  • 11 Nersesyan AK, Vardazaryan NS, Gevorgyan AL, Arutyunyan RM. Micronucleus level in exfoliated buccal mucosa cells of cancer patients. Arch Oncol 2002;10:35-6.
  • 12 Tolbert PE, Shy CM, Allen JW. Micronuclei and other nuclear anomalies in buccal smears: Methods development. Mutat Res 1992;271:69-77.
  • 13 Stich HF, Curtis JR, Bibhuti BP. Application of the MN test to exfoliated cells of high cancer risk groups-Tobacco chewers. Int J Cancer 1982;30:553-9.
  • 14 Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S. The Human Micronucleus Project: An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res 1999;428:271-83.
  • 15 Holland N, Bolognesi C, Volders M.K, Bonassi S, Zeiger E, Knasmueller S, et al. Review-The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: The HUMN project perspective on current status and knowledge gaps. Mutation Research 2008;659:93-108.
  • 16 Alexandrescu I, Havarneanu D, Popa D. New approaches in biomonitoring human populations exposed to genotoxic agents: Epithelial cell micronucleus assay. J Prev Med 2006;14:57-65.
  • 17 Offer T, Ho E, Traber MG, Bruno RS, Kuypers FA, Ames BN. A simple assay for frequency of chromosome breaks and loss (micronuclei) by flow cytometry of human reticulocytes. FASEB J 2005;19:485-7.
  • 18 Dauffaud F, Orisiere T, Pellisier AL, Volot F, Botta A. Comparison between micronucleated lymphocyte rates observed in healthy subjects and cancer patients. Mutagenesis 1997;12:227-31.
  • 19 Bloching M, Hofmann A, Lautenschlager C, Berghaus A, Grummt T. Exfoliative cytology of normal buccal mucosa to predict the relative risk of cancer in the upper aerodigestive tract using the MN-assay. Oral Oncol 2000;36:550-5.
  • 20 Yildirim IH, Yesilada E, Yologlu S. Micronucleus frequency in peripheral blood lymphocytes and exfoliated buccal cells of untreated cancer patients. Genetika 2006;42:705-10.
  • 21 Naderi NJ, Farhadi S, Sarshar S. Micronucleus assay of buccal mucosa cells in smokers with the history of smoking less and more than 10 years. Indian J Pathol Microbiol 2012;55:433-8.
  • 22 Bansal H, Sandhu VS, Bhandari R, Sharma D. Evaluation of micronuclei in tobacco users: A study in Punjabi population. Contemp Clin Dent 2012;3:184-7.
  • 23 Fenech M, Bonassi S, Turner J, Lando C, Ceppi M, Chang WP, et al. HUman MicroNucleus project. Intra- and inter-laboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes. Results of an international slide-scoring exercise by the HUMN project. Mutat Res 2003;534:45-64.
  • 24 Ribeiro DA, de Oliveira G, de Castro GM, Angelieri F. Research-cytogenetic biomonitoring in patients exposed to dental X-rays: Comparison between adults and children. Dentomaxillofac Radiol 2008;37:404-7.
  • 25 Ogden GR. Alcohol and oral cancer. Alcohol 2005;35:169-73.
  • 26 Ramirez A, Saldanha PH. Micronucleus investigation of alcoholic patients with oral carcinomas. Genet Mol Res 2002;1:246-60.
  • 27 Kashyap B, Reddy SP. Micronuclei assay of exfoliated oral buccal cells: Means to assess the nuclear abnormalities in different diseases. J Cancer Res Ther 2012;8:184-91.
  • 28 Casartelli G, Bonatti S, De Ferrari M, Scala M, Mereu P, Margarino G, et al. Micronucleus frequencies in exfoliated buccal cells in normal mucosa, precancerous lesions and squamous cell carcinoma. Anal Quant Cytol Histol 2000;22:486-492.
  • 29 Grover S, Mujib A, Jahagirdar A, Telagi N, Kulkarni PG. A comparative study for selectivity of micronuclei in oral exfoliated epithelial cells. J Cytol 2012;29:230-5.
  • 30 Nersesyan A, Kundi M, Atefie K, Schulte-Hermann R, Knasmuller S. Effect of staining procedures on the results of micronucleus assays with exfoliated oral mucosa cells. Cancer Epidemiol Biomarkers Prev 2006;15:1835-40.
  • 31 Ayyad SB, Israel E, El-Setouhy M, Nasr GR, Mohamed MK, Loffredo CA. Evaluation of Papanicolaou stain for studying micronuclei in buccal cells under field conditions. Acta Cytol 2006;50:398-402.
  • 32 Belien JA, Copper MP, Braakhuis BJ, Snow GB, Baak JP. Standardization of counting micronuclei: Definition of a protocol to measure genotoxic damage in human exfoliated cells. Carcinogenesis 1995;16:2395-400.